home / stock / agrx / agrx news


AGRX News and Press, Agile Therapeutics Inc. From 09/10/20

Stock Information

Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com

Menu

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AGRX - 4 Penny Stocks To Watch In September 2020; 1 Up Over 50% In Q3

Penny Stocks To Watch This Month Trading penny stocks is easy. You just find some letters, pull up the order-entry ticket, buy, sell, and profit, right? While the process of actually buying penny stocks is simple, the strategy isn’t quite as easy. Anyone can get lucky trading penny ...

AGRX - Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference

PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 22nd Annual G...

AGRX - Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020

Company to Present Twirla ® Commercial Plan Webcast Scheduled from 11:00 am – 1:00 pm EDT PRINCETON, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will host a virtual Investor/Ana...

AGRX - Agile Therapeutics Launches I'm So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control

Visit  BirthControlDoneMyWay.com to learn more about some of the many available contraceptive options I’m So Done is a national unbranded campaign intended to enhance the birth control conversation for women Encourage education on contraceptive care options Facilitate...

AGRX - Agile Therapeutics: Taking A Victory Lap While We Wait For Twirla's Commercial Launch

Agile Therapeutics (AGRX) struggled for years to get their once-weekly contraceptive patch, Twirla, approved by the FDA. Twirla received two CRLs from the FDA, which pummeled the share price into penny stock status, and investors' sentiment was abysmal. For two years, it looked as if the FDA w...

AGRX - 4 Penny Stocks To Buy According To Analysts; 1 Up 100% This Month

Where Do You Stand On These Penny Stocks Right Now? Penny stocks are well-known for their ability to breakout hugely in short timeframes. That’s the mystifying draw that brings traders to focus on stocks under $5. No matter who you talk to in the stock market today, everyone has the s...

AGRX - Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer

PRINCETON, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner, MD, MBA, to the position of Chief Medical Officer. Dr. Korner is a board-certified obstetrician a...

AGRX - MACK, MTP, CODX and IGC among midday movers

Gainers:  Midatech Pharma (NASDAQ: MTP ) +59% . More news on: Midatech Pharma plc, Mesoblast Limited, Sky Solar Holdings, Ltd., Stocks on the move, , Read more ...

AGRX - Agile Therapeutics -3.5% after Q2 earnings results are out

Agile Therapeutics ( AGRX -3.5% ) reports  Q2  net loss was $10.8M or EPS loss of $0.12 vs. net loss of $3.5M, or EPS loss of $0.08 in Q2 2019. More news on: Agile Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...

AGRX - Agile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q2 2020 Results - Earnings Call Transcript

Agile Therapeutics, Inc. (AGRX) Q2 2020 Earnings Conference Call August 11, 2020 16:30 ET Company Participants Matthew Riley - Investor Relations Alfred Altomari - Chairman, President & Chief Executive Officer Dennis Reilly - Senior Vice President & Chief Financial Office...

Previous 10 Next 10